Overview
The Effect of a Preoperative Single-dose Methylprednisolone on the Postoperative Rehabilitation After Abdominal Hysterectomy
Status:
Completed
Completed
Trial end date:
2011-10-01
2011-10-01
Target enrollment:
0
0
Participant gender:
Female
Female
Summary
The purpose of this study is to evaluate the effect of 125 mg methylprednisolone, given intravenously 60-90 minutes before abdominal surgery,on the postoperative rehabilitation after abdominal hysterectomy.Sodium Chloride is the placebo. The following parameters are registered: 1. Pain 3, 6 and 24 hours postoperatively and 2-7 days after surgery. 2. The postoperative use of additional analgesics. 3. Inflammatory parameters before and after surgery. 4. Time until mobilization. 5. Time until discharge.Phase:
Phase 4Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Holbaek SygehusTreatments:
Methylprednisolone
Methylprednisolone Acetate
Methylprednisolone Hemisuccinate
Prednisolone
Prednisolone acetate
Prednisolone hemisuccinate
Prednisolone phosphate
Criteria
Inclusion Criteria:- Patients having an abdominal hysterectomy on a benign indication.
- Patients who speak and understand Danish.
- Patients who can give informed consent.
Exclusion Criteria:
- Diabetics
- Regular use of glucocorticoids, opioids or tranquilizers
- Regular treatment with immunosuppressives
- Alcohol or drug abuse
- Morphine intolerance
- Age under 18
- Chronic pain disease eg fibromyalgia, rheumatoid arthritis
- Malign indication for hysterectomy
- BMI over 35
- Decreased kidney function
- ASA III or IV